00572nas a2200205   4500000000100000000000100001008004100002100001200043700001400055700003100069700001300100700001400113700001800127700001500145700001600160245014000176300001100316490000700327022003200334       2002                            d1 aC. Koro1 aD. Fedder1 aG. L\textquoterightItalien1 aS. Weiss1 aL. Magder1 aJ. Kreyenbuhl1 aD. Revicki1 aR. Buchanan00aAn assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients  a1021-60 v59  a0003-990X (Print) 0003-990x